Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Mac Sweeney

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|April 20, 2017
Prolonged glucocorticoid treatment in acute respiratory distress syndrome - Authors' replyRob Mac Sweeney, Daniel F McAuley
Lancet (London, England)|May 3, 2016
Acute respiratory distress syndromeRob Mac Sweeney, Daniel F McAuley
International Anesthesiology Clinics|March 14, 2019
Social Media in Critical CareKealan P Barrett, Rob Mac Sweeney
Thorax|April 17, 2012
Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?Rob Mac Sweeney, Daniel Francis McAuley
Seminars in Respiratory and Critical Care Medicine|August 13, 2013
Treatment of acute lung injury: current and emerging pharmacological therapiesRob Mac Sweeney, Mark Griffiths, Danny McAuley
NEJM Evidence|December 24, 2024
On "Blood Pressure Targets for Adults with Vasodilatory Shock"Rob Mac Sweeney, C Corey Hardin, François Lamontagne
The Ulster Medical Journal|February 8, 2014
Perioperative intravenous fluid therapy for adultsRob Mac Sweeney, Rachel Alexandra McKendry, Amit Bedi
Critical Care (London, England)|December 24, 2010
Beta 2 antagonism in acute respiratory failureRob Mac Sweeney, P J Devereaux, Daniel F McAuley
Seminars in Respiratory and Critical Care Medicine|October 13, 2011
Acute lung failureRob Mac Sweeney, Daniel F McAuley, Michael A Matthay
Critical Care Science|April 1, 2026
The PaO2/FiO2 is a weak predictor of mortality for critically ill patients: limitations of an easy-to-calculate scoreSusana Mendes Fernandes, Rob Mac Sweeney, João Gonçalves Pereira
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|April 20, 2017
Prolonged glucocorticoid treatment in acute respiratory distress syndrome - Authors' replyRob Mac Sweeney, Daniel F McAuley
Lancet (London, England)|May 3, 2016
Acute respiratory distress syndromeRob Mac Sweeney, Daniel F McAuley
International Anesthesiology Clinics|March 14, 2019
Social Media in Critical CareKealan P Barrett, Rob Mac Sweeney
Thorax|April 17, 2012
Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?Rob Mac Sweeney, Daniel Francis McAuley
Seminars in Respiratory and Critical Care Medicine|August 13, 2013
Treatment of acute lung injury: current and emerging pharmacological therapiesRob Mac Sweeney, Mark Griffiths, Danny McAuley
NEJM Evidence|December 24, 2024
On "Blood Pressure Targets for Adults with Vasodilatory Shock"Rob Mac Sweeney, C Corey Hardin, François Lamontagne
The Ulster Medical Journal|February 8, 2014
Perioperative intravenous fluid therapy for adultsRob Mac Sweeney, Rachel Alexandra McKendry, Amit Bedi
Critical Care (London, England)|December 24, 2010
Beta 2 antagonism in acute respiratory failureRob Mac Sweeney, P J Devereaux, Daniel F McAuley
Seminars in Respiratory and Critical Care Medicine|October 13, 2011
Acute lung failureRob Mac Sweeney, Daniel F McAuley, Michael A Matthay
Critical Care Science|April 1, 2026
The PaO2/FiO2 is a weak predictor of mortality for critically ill patients: limitations of an easy-to-calculate scoreSusana Mendes Fernandes, Rob Mac Sweeney, João Gonçalves Pereira
Pageof 2